1. 2638 Effectiveness of 2nd-line and subsequent therapies after pazopanib (Paz) in patients (pt) with metastatic renal cell carcinoma (mRCC): Final results of the SPAZO study (SOGUG). (September 2015) Authors: Arija, J.A. Arranz; Pérez-Valderrama, B.; González-Larriba, J.L.; Rodríguez Sánchez, A.; Chirivella, I.; Pinto, A.; Marrero, R.D. García; Rubio, G.; García, J.M. Jurado; Borrega, P.; Quintela, M. Lázaro; Castellano, D.E.; Rodríguez, C. Suárez; García, J.A. Meana; Lambea-Sorrosal, J.J.; Gajate, P.... Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗